Cristina Sánchez‐Mora

Montreal Neurological Institute and Hospital — Canada

Medicine · Health Sciences

38h-index11.8kcitations107works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Attention Deficit Hyperactivity Disorder(54), Genetic Associations and Epidemiology(22), Bipolar Disorder and Treatment(17), Genetics and Neurodevelopmental Disorders(17), Neurotransmitter Receptor Influence on Behavior(12)

Publications88 total

Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke
Neurology·2022· 31 citedOpen Access
Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes
International Journal of Epidemiology·2022· 23 citedOpen Access
Genetic Contributions to Early and Late Onset Ischemic Stroke
2021Open Access
TH4. A CAUSAL ROLE FOR ATTENTION DEFICIT/ HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION
European Neuropsychopharmacology·2021
Continuity of Genetic Risk for Aggressive Behavior Across the Life-Course
Behavior Genetics·2021· 23 citedOpen Access
Genetic association study of childhood aggression across raters, instruments, and age.
2021Open Access
Genetic association study of childhood aggression across raters, instruments, and age
Translational Psychiatry·2021· 74 citedOpen Access
Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder
Translational Psychiatry·2021· 61 citedOpen Access
New Distance-Based approach for Genome-Wide Association Studies
IEEE/ACM Transactions on Computational Biology and Bioinformatics·2021· 1 citedOpen Access
Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality
Molecular Psychiatry·2021· 4 citedOpen Access
Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
Nature Communications·2021· 3 citedOpen Access
Brain structural and functional substrates of ADGRL3 (latrophilin 3) haplotype in attention-deficit/hyperactivity disorder
Scientific Reports·2021· 6 citedOpen Access
Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
Nature Communications·2021· 49 citedOpen Access
Integrating genomics and transcriptomics: Towards deciphering ADHD
European Neuropsychopharmacology·2021· 10 citedOpen Access
Genetic overlap and causality between substance use disorder and <scp>attention‐deficit</scp> and hyperactivity disorder
American Journal of Medical Genetics Part B Neuropsychiatric Genetics·2020· 33 citedOpen Access
Transcriptome profiling in adult attention-deficit hyperactivity disorder
European Neuropsychopharmacology·2020· 14 citedOpen Access
Exploring allele specific methylation in drug dependence susceptibility
Journal of Psychiatric Research·2020· 3 citedOpen Access
Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults
Translational Psychiatry·2020· 25 citedOpen Access
Shared genetic background between children and adults with attention deficit/hyperactivity disorder
Neuropsychopharmacology·2020· 102 citedOpen Access
Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility
Molecular Psychiatry·2020· 36 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Marta Ribasès(46), Josep Antoni Ramos‐Quiroga(41), Miguel Casas(38), Bru Cormand(28), Rosa Bosch(20), Vanesa Richarte(20), Iris Garcia‐Martínez(17), Jan Haavik(14), Klaus‐Peter Lesch(14), Andreas Reif(14), Barbara Franke(14), Paula Rovira(13), María Soler Artigas(13), Stefan Johansson(12), Montse Corrales(11), Christian Jacob(10), Mónica Bayés(10), Mireia Pagerols(10), Jan K. Buitelaar(9), Stephen V. Faraone(9)